N-Acetylcysteine Therapy for Unverricht-Lundborg Disease
Neurol 52:426-427, Selwa,L.M., 1999
Treatment of Absence Status with Intravenous Valproate
Neurol 52:889-890, Alehan,F.K.,et al, 1999
Medical Management of Epilepsy in Adults
Neurol 51:S15-S20, Mattson,R.H., 1999
MRI Abnormalities Associated with Partial Status Epilepticus
Neurol 52:1021-1027, Lansberg,M.G.,et al, 1999
What Level of Care for the Neurofibromatoses?
Lancet 353:1114-1116, Huson,S.M., 1999
Familial Subarachnoid Hemorrhage, Outcome Study
Stroke 30:1099-1102, Ronkainen,A.,et al, 1999
Oculogyric Crisis as an Initial Manifestation of Wilson's Disease
Neurol 52:714-715, Lee,M.S.,et al, 1999
A Randomized Placebo-Controlled Comparative Trial of Gabapentin and Propranolol in Essential Tremor
Arch Neurol 56:475-480, Gironell,A.,et al, 1999
Rapidly Progressive Dementia
Lancet 353:1150, Bornke,C.,et al, 1999
Is Cyclic Vomiting Syndrome Related to Migraine?
J Pediatr 134:567-572, 533, Li,B.U.K.,et al, 1999
Cat-Scratch Disease Encephalopathy:A Cause of Status Epilepticus in School-Aged Children
J Pediatrics 134:635-638, Armengol,C.E.&Hendley,J.O., 1999
MR Imaging of Dejerine-Sottas Disease
AJNR 20:378-380, Make,D.D.,et al, 1999
Sjogren-Larsson Syndrome, Clinical and MRI/MRS Findings in FALDH-Deficient Patients
Neurol 52:1345-1352,1307, Van Domburg,P.H.M.F.,et al, 1999
Hyperintense Basal Ganglia on T1-Weighted MR Imaging
AJR 172:1109-1115, Lai,P.H.,et al, 1999
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999
Vagus Nerve Stimulation for Medication-Resistant Generalized Epilepsy
Neurol 52:1510-1512, Labar,D.,et al, 1999
Left Vagal nerve Stimulation in Children with Medically Refractory epilepsy
J Pediatr 134:563-566, 532, Murphy,J.V.&Pediatric VNS Study Group, 1999
Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999
Vagal Nerve Stimulation in epileptic Encephalopathies
Pediatrics 103:778-782, 821, Parker,A.P.J.,et al, 1999
Supratentorial Cavernous Haemangiomas and Epilepsy:A Review of the Literature and Case Series
JNNP 66:561-568, Moran,N.F.,et al, 1999
Intractable Epilepsy
Lancet 353:1238, Shuper,A.,et al, 1999
Familial Paroxysmal Dystonic Choreoathetosis,Clinical Findings in a Large Japanese Family and Genetic Linkage to 2q
Arch Neurol 56:721-726, Matsuo,H.,et al, 1999
Salvage Chemotherapy with Tamoxifen for Recurrent Anaplastic Astrocytomas
Arch Neurol 56:703-708, Chamberlain,M.C.&Kormanik,P.A., 1999
Serial Magnetic Resonance Imaging of Cerebral Atrophy in Preclinical Alzheimer's Disease
Lancet 353:2125, Fox,N.C.,et al, 1999
Molecular Basis of the Neurodegenerative Disorders
NEJM 340:1970-1980, Martin,J.B., 1999
Stereotactic Radiosurgical Pallidotomy and Thalamotomy with the Gamma Knife:MR Imaging Findings with Clinical Correlation-Preliminary Experience
Radiology 212:143-150, Friedman,D.P.,et al, 1999
Absent Pachymeningeal Gadolinium Enhancement on Cranial MRI Despite Symptomatic CSF Leak
Neurol 53:402-404, Mokri,B.,et al, 1999
Seizure Control and Mortality in Epilepsy
Ann Neurol 46:45-50, Sperling,M.R.,et al, 1999
Prethrombotic Disorders in Children with Arterial Ischemic Stroke and Sinovenous Thrombosis
Arch Neurol 56:967-971, Bonduel,M.,et al, 1999
Cerebroretinal Vasculopathy Mimicking a Brain Tumor:A Case of a Rare Hereditary Syndrome
Neurol 53:629-631, Weil,S.,et al, 1999
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Superficial Siderosis of the CNS Associated with Multiple Cavernous Malformations
AJNR 20:1245-1248, Whu,W.C.,et al, 1999
Rapid-Onset Dystonia-Parkinsonism:Linkage to Chromosome 19q13
Ann Neurol 46:176-182, Kramer,P.L.,et al, 1999
Antiplatelet Treatment Does Not Reduce the Severity of Subsequent Stroke
Neurol 53:825-829, Sivenius,J.,et al, 1999
Patient-Oriented Outcome Assessment After Temporal Lobectomy for Refractory Epilepsy
Neurol 53:687-694, 662, Gilliam,F.,et al, 1999
Reassessment:Vagus Nerve Stimulation for Epilepsy
Neurol 53:666-669, Fisher,R.S.&Handforth,A., 1999
Aneurysms in Relatives of Patients with Subarachnoid Hemorrhage,Frequency and Risk Factors
Neurol 53:982-988, Raaymakers,T.W.M.&the MARS Study Group, 1999
MRI Detection of New Hemorrhages:Potential Marker of Progression in Cerebral Amyloid Angiopathy
Neurol 53:1135-1138, Greenberg,S.M.,et al, 1999
The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999
When to Start and Stop Anticonvulsant Therapy in Children
Arch Neurol 56:1073-1077, Greenwood,R.S.&Tennison,M.B., 1999
Clinical and MRI Findings in Spinocerebellar Ataxia Type 5
Neurol 53:1355-1357, Stevanin,G.,et al, 1999
Risks and Benefits of Screening for Intracranial Aneurysms in First-Degree Relatives of Patients with Sporadic Subarachnoid Hemorrhage
NEJM 341:1344-1350, The Magnetic Resonance Angiography in Relatives of, 1999
New Developments in the Neurobiology of the Tuberous Sclerosis Complex
Neurol 53:1384-1390, Crino,P.B.&Henske,E.P., 1999
Bilateral Thalamic Stimulation for the Treatment of Essential Tremor
Neurol 53:1447-1450, Pahwa,R.,et al, 1999
Neuropsychological and Quality of Life Outcome after Thalamic Stimulation for Essential Tremor
Neurol 53:1774-1780, Troster,A.I.,et al, 1999
Altered Brain Activation in Cognitively Intact Individuals at High Risk for Alzheimer's Disease
Neurol 53:1391-1396, Smith,C.D.,et al, 1999
A Modified Epley's Procedure for Self-Treatment of Benign Paroxysmal Positional Vertigo
Neurol 53:1358-1360, Radtke,A.,et al, 1999
Benign paroxysmal Positional Vertigo
NEJM 341:1590-1596, Furman,J.M .&Cass,S.P., 1999